The information you provide to the chat will be recorded to improve your experience and to contact you. Please read our privacy notice to see how we are processing and protecting your data. Click to view our Cookie Notice.
We'd love your feedback—take a quick survey to help us improve.
How can we help you today?
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Thermo Fisher Scientific
Impact of Accelerator™ Drug Development:
One partner, real results
Case studies
In pharmaceutical development, relying on disconnected providers often leads to knowledge and service gaps, causing significant delays and missed opportunities.
Thermo Fisher Scientific's Accelerator™ Drug Development streamlines the entire journey by integrating a full suite of CDMO and CRO services as core offerings and supporting each step—from preclinical to commercial—across all major drug modalities and therapeutic areas.
We help developers of all sizes navigate complexity, meet milestones efficiently, and reduce interruptions, with an approach that eliminates timeline gaps and mitigates risks.
The case studies below showcase how our fully integrated, end-to-end approach has made a measurable difference for organizations like yours.
Streamlining preclinical pathways for a faster transition to First-in-Human trials
When API and study design complications threatened progress, integrated preclinical solutions within the Accelerator™ Drug Development framework helped to reduce risk and drive efficiency.
Integrated governance drives execution across global clinical research program
Discover how Accelerator™ Drug Development enabled the fragmented internal team of a global biopharma sponsor manage multiple parallel studies—and meet enrollment goals.
Collaborative timeline management drives speed and simplicity in global vaccine trial
See how integration and foresight helped identify and resolve potential bottlenecks before they affected an FPI milestone, turning a high-risk timeline into repeatable success.